These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21167313)

  • 1. Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data.
    Van den Bulcke T; Vanden Broucke P; Van Hoof V; Wouters K; Vanden Broucke S; Smits G; Smits E; Proesmans S; Van Genechten T; Eyskens F
    J Biomed Inform; 2011 Apr; 44(2):319-25. PubMed ID: 21167313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
    Tran K; Banerjee S; Li H; Noorani HZ; Mensinkai S; Dooley K
    Clin Biochem; 2007 Feb; 40(3-4):235-41. PubMed ID: 17222812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Maier EM; Liebl B; Röschinger W; Nennstiel-Ratzel U; Fingerhut R; Olgemöller B; Busch U; Krone N; v Kries R; Roscher AA
    Hum Mutat; 2005 May; 25(5):443-52. PubMed ID: 15832312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCAD deficiency in Denmark.
    Andresen BS; Lund AM; Hougaard DM; Christensen E; Gahrn B; Christensen M; Bross P; Vested A; Simonsen H; Skogstrand K; Olpin S; Brandt NJ; Skovby F; Nørgaard-Pedersen B; Gregersen N
    Mol Genet Metab; 2012 Jun; 106(2):175-88. PubMed ID: 22542437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.
    Tajima G; Sakura N; Yofune H; Nishimura Y; Ono H; Hasegawa Y; Hata I; Kimura M; Yamaguchi S; Shigematsu Y; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):122-30. PubMed ID: 16046200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome.
    Joy P; Black C; Rocca A; Haas M; Wilcken B
    Child Neuropsychol; 2009 Jan; 15(1):8-20. PubMed ID: 18608229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].
    Simonsen H
    Ugeskr Laeger; 2002 Nov; 164(48):5607-12. PubMed ID: 12523003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
    Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
    Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Ho S; Lukacs Z; Hoffmann GF; Lindner M; Wetter T
    Clin Chem; 2007 Jul; 53(7):1330-7. PubMed ID: 17513288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Najdekr L; Gardlo A; Mádrová L; Friedecký D; Janečková H; Correa ES; Goodacre R; Adam T
    Talanta; 2015 Jul; 139():62-6. PubMed ID: 25882409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-chain acyl-CoA dehydrogenase deficiency in Saudi Arabia: incidence, genotype, and preventive implications.
    Al-Hassnan ZN; Imtiaz F; Al-Amoudi M; Rahbeeni Z; Al-Sayed M; Al-Owain M; Al-Zaidan H; Al-Odaib A; Rashed MS
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S263-7. PubMed ID: 20567907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.
    Yusupov R; Finegold DN; Naylor EW; Sahai I; Waisbren S; Levy HL
    Mol Genet Metab; 2010 Sep; 101(1):33-9. PubMed ID: 20580581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.
    Hamers FF; Rumeau-Pichon C
    BMC Pediatr; 2012 Jun; 12():60. PubMed ID: 22681855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal medium-chain acyl-CoA dehydrogenase deficiency identified by newborn screening.
    Leydiker KB; Neidich JA; Lorey F; Barr EM; Puckett RL; Lobo RM; Abdenur JE
    Mol Genet Metab; 2011 May; 103(1):92-5. PubMed ID: 21354840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new enzymatic diagnosis method for very-long-chain Acyl-CoA dehydrogenase deficiency by detecting 2-hexadecenoyl-CoA production and its application in tandem mass spectrometry-based selective screening and newborn screening in Japan.
    Tajima G; Sakura N; Shirao K; Okada S; Tsumura M; Nishimura Y; Ono H; Hasegawa Y; Hata I; Naito E; Yamaguchi S; Shigematsu Y; Kobayashi M
    Pediatr Res; 2008 Dec; 64(6):667-72. PubMed ID: 18670371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supervised machine learning techniques for the classification of metabolic disorders in newborns.
    Baumgartner C; Böhm C; Baumgartner D; Marini G; Weinberger K; Olgemöller B; Liebl B; Roscher AA
    Bioinformatics; 2004 Nov; 20(17):2985-96. PubMed ID: 15180934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
    Goddard P
    J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.